GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the street drug side effects
Background
Major depression affects about 10 percent of the adult population and is the second leading cause of disability in U.S. adults, according to the World Health Organization. Despite the availability of several different classes of antidepressant drugs such as selective serotonin reuptake inhibitors (SSRIs), 30 to 40 percent of adults are unresponsive to these medications. Moreover, SSRIs typically take weeks to work, which increases the risk for suicide.
Enter NMDA (N-methyl-D-aspartate) receptor modulators. In the 1970s, researchers linked the receptors to learning and memory. Biotech and pharmaceutical companies in the 1980s attempted to apply chemical blockers to these receptors as a means to prevent stroke. But blocking these receptors led to the opposite effect—–the rise of cardiovascular disease. Research in the field dampened until a glutamate receptor antagonist already approved for anesthesia, and known on the streets as “Special K”, ketamine, made headlines in the early 2000s. Human clinical studies demonstrated that ketamine can ward off major and bipolar depressive symptoms within 2 hours of administration and last for several days. Ketamine is fraught with serious side effects including excessive sleepiness, hallucinations, and substance abuse behavior.
“Ketamine lit the field back up,“ said Joseph Moskal, Ph.D., a molecular neurobiologist at Northwestern University and senior study author. “Our drug, GLYX-13, is very different. It does not block the receptor ion channel, which may account for why it doesn’t have the same side effects.”
Moskal’s journey with GLYX-13 came about from his earlier days as a Senior Staff Fellow in NIMH’s Intramural Research Program. While at NIMH, he created specific molecules, monoclonal antibodies, to use as new probes to understand pathways of learning and memory. Some of the antibodies he created were for NMDA receptors. When he moved to Northwestern University, Moskal converted the antibodies to small protein molecules. Comprised of only four amino acids, GLYX-13 is one of these molecules.
Previous electrophysiological and conditioning studies had suggested that GLYX-13, unlike ketamine, enhanced memory and learning in rats, particularly in the brain’s memory hub or hippocampus. GLYX-13 also produced analgesic effects. Using several rat behavioral and molecular experiments, Moskal’s research team tested four compounds: GLYX-13, an inactive, “scrambled” version of GLYX-13 that had its amino acids rearranged, ketamine, and the SSRI fluoxetine.
Results of the Study
GLYX-13 and ketamine produced rapid acting (1 hour) and long-lasting (24 hour) antidepressant-like effects in the rats. Fluoxetine, an SSRI that typically takes from 2–4 weeks to show efficacy in humans, did not produce a rapid antidepressant effect in this study. As expected, the scrambled GLYX-13 showed no antidepressant-like effects at all. The researchers observed none of the aforementioned side effects of ketamine in the GLYX-13–treated rats.
Protein studies indicated an increase in the hippocampus of the NMDA receptor NR2B and a receptor for the chemical messenger glutamate called AMPA. Electrophysiology studies in this brain region showed that GLYX-13 and ketamine promoted long-lasting signal transmission in neurons, known as long-term potentiation/synaptic plasticity. This phenomenon is essential in learning and memory. The researchers propose how GLYX-13 works: GLYX-13 triggers NR2B receptor activation that leads to intracellular calcium influx and the expression of AMPA, which then is responsible for increased communication between neurons.
These results are consistent with data from a recent Phase 2 clinical trial, in which a single administration of GLYX-13 produced statistically significant reductions in depression scores in patients who had failed treatment with current antidepressants. The reductions were evident within 24 hours and persisted for an average of 7 days. After a single dose of GLYX-13, the drug’s antidepressant efficacy nearly doubled that seen with most conventional antidepressants after 4–6 weeks of dosing. GLYX-13 was well tolerated and it did not produce any of the schizophrenia-like effects associated with other NMDA receptor modulating agents.
The Latest Bing News on:
Major depression
- Noninvasive Brain Stimulation Shows Rapid Relief for Major Depressionon May 2, 2024 at 8:19 am
An RCT suggests transcranial alternating current stimulation may be an effective treatment for major depression, but outside experts say more study is needed to confirm its benefit.
- What Fitness Exercises Treat Depression the Best?on May 2, 2024 at 6:36 am
Dance, exercise combined with medication, and walking or jogging were most effective for relieving symptoms of depression. Yoga, strength training, mixed aerobic exercises, and tai chi or qigong were ...
- Gilgamesh starts subject dosing in major depressive disorder trialon May 1, 2024 at 8:50 pm
Gilgamesh Pharmaceuticals has commenced subject dosing in a Phase IIa clinical trial of GM-1020 to treat major depressive disorder (MDD). This clinical trial aims to evaluate the safety, tolerability, ...
- Depression Newson May 1, 2024 at 5:00 pm
Ketamine's Promise for Severe Depression Grows, but Major Questions Remain Feb. 8, 2024 — Using an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe ...
- Are Smartphones Driving Our Teens to Depression?on May 1, 2024 at 11:09 am
When the smartphone thesis first came to prominence more than six years ago, advanced by Haidt’s sometime collaborator Jean Twenge, there was a fair amount of skepticism from scientists and social ...
- Magnus Medical launches Saint neuromod system for major depressive disorder treatmenton May 1, 2024 at 9:43 am
Magnus Medical announced the commercial launch of its Saint neuromodulation system for treatment-resistant major depressive disorder (MDD).
- Women are more likely to experience depression during perimenopause, study reportson May 1, 2024 at 3:44 am
Researchers say women are more likely to experience depression symptoms during the perimenopause stage of their life rather than their postmenopause years. They say screening for depression is ...
- How to Talk to a Therapist about Depressionon April 30, 2024 at 8:14 am
By the nature of how depression manifests itself, it’s often hard for those in its grip to seek any support, let alone therapy. And while it may seem like everyone else isn’t struggling, there’s a ...
- Why Depression Can Make It Hard to Know You're Depressedon April 29, 2024 at 8:05 am
Depression often leads to an extremely negative view of oneself, and even to self-hatred. These feelings and beliefs can interfere with recognizing them as a symptom of depression because they seem so ...
- Billie Eilish Recalls Suffering Debilitating Depression Last Summer: 'I've Never Been a Happy Person'on April 24, 2024 at 10:46 am
In a 'Rolling Stone' cover story, Billie EIlish, 22, revealed she suffered a major bout of depression last summer, admitting that she’s “never been a happy person” ...
The Latest Google Headlines on:
Major depression
[google_news title=”” keyword=”Major depression” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Fix the internet
- 'It was quite a show': Escaped zebra caught in Washington yard after 6 days on the runon May 4, 2024 at 1:52 pm
Shrug, the remaining Zebra that escaped on April 28, was found in a Washington backyard after six days on the run.
- AT&T's Speed Fix Is A $7 Monthly Turbo Boost Add-On For Priority Accesson May 2, 2024 at 7:46 am
AT&T also alluded to the recent reinstatement of net neutrality rules, suggesting that its Turbo add-on does not run afoul of the FCC's regulations on internet connectivity. "Eligible customers will ...
- Give small businesses the ‘right to repair’on May 2, 2024 at 7:00 am
Thankfully, bipartisan members of Congress have introduced a commonsense proposal that would benefit small businesses and consumers: the Right to Equitable and Professional Auto Industry Repair Act.
- How to fix the Longbeard error in Sea of Thieveson May 2, 2024 at 6:56 am
Sea of Thieves the game’s server status Restart your modem and router: This can often fix temporary glitches with your internet connection. Change your DNS servers: Occasionally, using different DNS ...
- Chuck Todd: The race to build a better internet — before it's too lateon May 1, 2024 at 2:00 am
Reality check: "Any person in the U.S., regardless of their immigration status, may be entitled to many of the same constitutional rights as U.S. citizens, including the right to due process and equal ...
- 5 Ways to Fix the Failed-to-Connect-to-Server Minecraft Error on Windows PCson April 30, 2024 at 9:25 am
This troubleshooting guide provides some possible resolutions for fixing the Minecraft error message that says, “Failed to connect to the server.” Are you seeking a fix for that server connectivity ...
- Is your internet being throttled? How to test and fix your speedson April 30, 2024 at 7:24 am
Learn more about why internet providers throttle your internet speed, how to tell when it's happening and what to do to prevent it.
- 5 Ways to Fix the “No Servers Found” Apex Legends Error on a Windows PCon April 29, 2024 at 6:33 am
This KeenGamer page tells you about some of the ways players can fix the “No servers found” Apex Legends error. Does the “No servers found” error appear when you start Apex Legends on a Windows PC? If ...
- How to Fix the "No Internet Secured" Error on Windowson April 26, 2024 at 8:00 am
The message "No Internet, Secured" usually appears when your connection is weak. You can reboot your router to refresh your network, which might also improve its speed. Alternatively, you can also ...
- How to Fix Search Results in the Windows 11 Start Menuon April 24, 2024 at 3:01 pm
Windows 11's start menu, by default, searches the internet and your computer at once. Here's how to keep things local.
The Latest Google Headlines on:
Fix the internet
[google_news title=”” keyword=”fix the internet” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]